The Emory University science lab behind what could be a gamechanging COVID-19 pill.
19 Minuten
Podcast
Podcaster
Beschreibung
vor 4 Jahren
Drug company Merck is awaiting word on its emergency
use-authorization application for its recently announced drug
molnupiravir. If approved, the anti-viral drug developed at a lab
at Emory University could become the first-ever pill to treat
COVID-19. The latest Georgia Today podcast examines the journey
that led to this potential breakthrough and its connection to
Emory.
use-authorization application for its recently announced drug
molnupiravir. If approved, the anti-viral drug developed at a lab
at Emory University could become the first-ever pill to treat
COVID-19. The latest Georgia Today podcast examines the journey
that led to this potential breakthrough and its connection to
Emory.
Weitere Episoden
16 Minuten
vor 11 Monaten
16 Minuten
vor 11 Monaten
15 Minuten
vor 11 Monaten
21 Minuten
vor 11 Monaten
9 Minuten
vor 11 Monaten
In Podcasts werben
Kommentare (0)